Generic placeholder image

Current Microwave Chemistry

Editor-in-Chief

ISSN (Print): 2213-3356
ISSN (Online): 2213-3364

Research Article

Significance of Microwave Irradiation in Synthesis of Thiazolidin-4-one Bearing Pyrimidine Analogues: Their in vitro Antimicrobial, Antituberculosis and Antimalarial Studies

Author(s): Navin B. Patel*, Hetal I. Soni and Rahul B. Parmar

Volume 7 , Issue 3 , 2020

Page: [230 - 237] Pages: 8

DOI: 10.2174/2213335607999200918155613

Price: $65

Abstract

Aims: To synthesise biologically active thiazolidin-4-one by microwave irradiation method and evaluate against different species of bacteria, fungi and Plasmodium falciparum.

Background: Microwave irradiation method is serviceable for rapid and sustainable synthesis. In this present study, Thiazolidin-4-one bearing pyrimidine derivatives have been synthesized by microwave irradiation method.

Objective: Thiazolidin-4-one is a valuable motif because of its broad-spectrum biological evaluation. It is famous for many types of biological profiles, mainly antimicrobial, anti-tuberculosis, anti- convulsant, antihypertensive, hypoglycemic agent and antimalarial. This biological response leads our attention towards the change of Thiazolidin-4-one skeleton to enhance potential. Present study aims to carry out a rapid synthesis of Thiazolidin-4-one derivative of pyrimidine by microwave- assisted heating.

Methods: 4-(4-substituted phenyl)-6-(substituted aryl) pyrimidin-2-amine was the key intermediate required for the synthesis of 3-(4-(Substituted phenyl)-6-(substituted aryl) pyrimidin-2-yl)-2-(4-hydroxy phenyl) thiozolidin-4-one (5A-J), which was prepared by using microwave irradiation. The structures of all newly synthesized motifs were characterized by spectral analysis (IR, 1H NMR, 13C NMR spectroscopy) and screened for antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus pyogenes; antifungal activity against Candida albicans, Aspergillus niger, Aspergillus Clavatus; anti-tuberculosis activity against M. tuberculosis H37RV and antimalarial activity against Plasmodium falciparum.

Results: Higher yield with less time-consuming method is the main advantage of Thiazolidin- 4-one bearing pyrimidine motifs synthesis. The excellent biological response of compounds 5B, 5C, 5D, 5G, 5H, 5I, and 5J was observed.

Conclusion: As compared to conventional method, less time is required for the preparation of Thiazolidin- 4-one analogues by using advantageous microwave irradiation method. Thiazolidin-4-one derivatives showed improved biological activity.

Keywords: Thiazolidin-4-ones, Antibacterial, Antifungal, Anti-tubercular H37RV, Antimalarial, Aspergillus Clavatus.

Graphical Abstract
[1]
Jain, A.K.; Vaidya, A.; Ravichandran, V.; Kashaw, S.K.; Agrawal, R.K. Recent developments and biological activities of thiazolidinone derivatives: a review. Bioorg. Med. Chem., 2012, 20(11), 3378-3395.
[http://dx.doi.org/10.1016/j.bmc.2012.03.069] [PMID: 22546204]
[2]
Antus, S.; Gulacsi, K.; Juhasz, L.; Kiss, L.; Kurtan, T. Synthesis of naturallyoccurring o-heterocyclic compounds of biological activity. Pure Appl. Chem., 2004, 76, 1025-1032.
[http://dx.doi.org/10.1351/pac200476051025]
[3]
Ansari, K.F.; Lal, C. Synthesis and biological activity of some heterocyclic compounds containing benzimidazole and beta-lactam moiety. J. Chem. Sci., 2009, 121, 1017-1025.
[http://dx.doi.org/10.1007/s12039-009-0114-8]
[4]
Mostafa, T.B. Synthesis and modification of some heterocyclic compounds with potential biological activity coupled on poly (maleic anhydride “methyl methacrylate). J. Am. Sci., 2010, 6, 512-524.
[5]
Salimon, J.; Salih, N.; Hussien, H.; Yousif, E. Synthesis and characterization of new heterocyclic compounds derived from 2-aminopyridine. Eur. J. Sci. Res., 2009, 31, 256-264.
[6]
Singh, A.K.; Mishra, G.; Jyoti, K.J. Review on biological activities of 1,3,4-thiadiazole derivatives. J. Appl. Pharm. Sci., 2011, 1, 44-49.
[7]
Deshmukh, A.R.; Bhosle, M.R.; Khillare, L.D.; Dhumal, S.T.; Mishra, A.; Shrivastava, A.K.; Mane, R.A. New tetrazoloquinolinyl methoxyphenyl-4- thiazolidinones: synthesis and antihyperglycemic evaluation. Res. Chem. Intermed., 2017, 43, 1107-1120.
[http://dx.doi.org/10.1007/s11164-016-2686-5]
[8]
Devprakash, Bhoi U.A.A. Complete review of thiazolidine-4-ones. J. Pharma Res., 2011, 4, 2436-2440.
[9]
Cheon, C.W.; Kim, D.H.; Kim, D.H.; Cho, Y.H.; Kim, J.H. Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J. Gastroenterol., 2009, 15(3), 310-320.
[http://dx.doi.org/10.3748/wjg.15.310] [PMID: 19140230]
[10]
Walmik, P.; Naraboli, B.S.; Swathi, B.; Ghanti, S. Design, Synthesis of biologically active heterocyles containing indol-thiazolylthiazolidinone derivatives. Pharma Chem., 2017, 9, 8-12.
[11]
Srinivas, A.; Nagaraj, A.; Reddy, C.S. Synthesis and in vitro study of methylene-bis-tetrahydro[1,3]thiazolo[4,5-c]isoxazoles as potential nematicidal agents. Eur. J. Med. Chem., 2010, 45(6), 2353-2358.
[http://dx.doi.org/10.1016/j.ejmech.2010.02.014] [PMID: 20199825]
[12]
Beniwal, M.; Jain, N. Microwave assisted synthesis, characterization and antimicrobial screening of thiazolidin-4-one substituted pyrazole derivatives. Curr. Microw. Chem., 2019, 6, 44-53.
[http://dx.doi.org/10.2174/2213335606666190722144956]
[13]
Patel, N.B.; Patel, S.D. Synthesis and antimicrobial activity of 2-phenyl-3-1-cyclopropyl-6-fluoro-7-[4-methylpiperazin-1-yl]-4-quinolonecarboxamido-3-thiazolidin-4-ones. Pharm. Chem. J., 2009, 43, 305-310.
[http://dx.doi.org/10.1007/s11094-009-0300-5]
[14]
Patel, N.B.; Shaikh, F.M. Synthesis and antimicrobial activity of new 4-thiazolidinone derivatives containing 2-amino-6-methoxybenzothiazole. Saudi Pharm. J., 2010, 18(3), 129-136.
[http://dx.doi.org/10.1016/j.jsps.2010.05.002] [PMID: 23964172]
[15]
Singh, I.; Kumar, A. Synthesis of thiazolidinone and azetidinone derivatives of benzoxazolinone as antimicrobial agents. Int. J. Pharm. Sci. Res., 2015, 6, 850-856.
[16]
Patel, N.B.; Pathak, K.K. Pyridoquinolones containing azetidinones: Synthesis and their biological evaluation. Med. Chem. Res., 2011, 21, 2044-2055.
[http://dx.doi.org/10.1007/s00044-011-9728-8]
[17]
Kaur, H.; Kumar, S.; Vishwakarma, P.; Sharma, M.; Saxena, K.K.; Kumar, A. Synthesis and antipsychotic and anticonvulsant activity of some new substituted oxa/thiadiazolylazetidinonyl/thiazolidinonylcarbazoles. Eur. J. Med. Chem., 2010, 45(7), 2777-2783.
[http://dx.doi.org/10.1016/j.ejmech.2010.02.060] [PMID: 20392546]
[18]
Patel, N.B.; Patel, M.D. Synthesis and evaluation of antibacterial and antifungal activities of 4-thiazolidinones and 2- azetidinones derivatives from chalcones. Med. Chem. Res., 2017, 26, 1772-1783.
[http://dx.doi.org/10.1007/s00044-017-1837-6]
[19]
Kapoor, G.; Pathak, D.P.; Bhutani, R. Ravikant. Thiazolidinone as a pharmacologically active molecule. J. Chem. Pharm. Res., 2016, 8, 151-168.
[20]
Desai, N.C.; Patel, B.Y.; Jadeja, K.A.; Dave, B.P. landscaping of quinoline based heterocycles as potential antimicrobial agents: A mini review. Nov. Appro. Drug Des. Dev., 2017, 1, 555570.
[http://dx.doi.org/10.19080/NAPDD.2017.01.555570]
[21]
Andres, C.J.; Bronson, J.J.; D’Andrea, S.V.; Deshpande, M.S.; Falk, P.J.; Grant-Young, K.A.; Harte, W.E.; Ho, H.T.; Misco, P.F.; Robertson, J.G.; Stock, D.; Sun, Y.; Walsh, A.W. 4-Thiazolidinones: novel inhibitors of the bacterial enzyme MurB. Bioorg. Med. Chem. Lett., 2000, 10(8), 715-717.
[http://dx.doi.org/10.1016/S0960-894X(00)00073-1] [PMID: 10782671]
[22]
Lancaster, M. Green Chemistry: An Introductory Text; Royal Society of Chemistry: Cambridge, 2010, pp. 1-16.
[23]
Joshi, U.J.; Gokhale, K.M.; Kanitkar, A.P. Green Chemistry: Need of the Hour, Indian J. Pharm. Educ. Res., 2011, 45, 168-174.
[24]
Ravichandran, S.; Karthikeyan, E. Microwave synthesis: A potential tool for green Chemistry. Int. J. Chemtech Res., 2011, 3, 466-470.
[25]
Patel, N.B.; Pathan, S.S.; Soni, H.I. 3,4-dihydropyrimidin-2(1 h)-one analogues: microwave irradiated synthesis with antimicrobial and antituberculosis study. Curr. Microw. Chem., 2019, 6, 61-70.
[http://dx.doi.org/10.2174/2213335606666190724093305]
[26]
Adhikari, A.; Kalluraya, B.; Kizhakke, V.S.; Kuluvar, G.; Mahmood, R. Microwave assisted synthesis of novel thiazolidinone analogues as possible bioactive agents. J. Adv. Res., 2012, 3, 325-330.
[http://dx.doi.org/10.1016/j.jare.2011.10.003]
[27]
Gore, R.P. Microwave assisted synthesis and characterization of azole thiazolidinone acetamides. J. Pharma Res., 2014, 8(11), 1624-1627.
[28]
Pitta, E.; Tsolaki, E.; Geronikaki, A.; Petrovic, J.; Glamoclija, J.; Sokovic, M.; Crespan, E.; Maga, G.; Bhuniade, S.S.; Saxenade, A.K. 4-Thiazolidinone derivatives as potent antimicrobial agents: microwave-assisted synthesis, biological evaluation and docking studies. Med Chem Comm, 2014.
[http://dx.doi.org/10.1039/c4md00399c]
[29]
El Azab, I.H.; Abdel-Hafez, Sh.H. One-pot three-component microwave-assisted synthesis of novel thiazolidinone derivatives containing thieno[d]pyrimidine-4-one moiety as potential antimicrobial agents. Bioorg. Khim., 2015, 41(3), 357-365.
[http://dx.doi.org/10.7868/S0132342315030021] [PMID: 26502612]
[30]
Bacsa, B.; Bosze, S.; Kappe, C.O. Direct solid-phase synthesis of the beta-amyloid (1-42) peptide using controlled microwave heating. J. Org. Chem., 2010, 75(6), 2103-2106.
[http://dx.doi.org/10.1021/jo100136r] [PMID: 20180552]
[31]
Soni, H.I.; Patel, N.B. Pyrimidine incorporated schiff base of isoniazid with their synthesis, characterization and in vitro biological evaluation. Asian J. Pharm. Clin. Res., 2017, 10, 209-214.
[http://dx.doi.org/10.22159/ajpcr.2017.v10i10.19302]
[32]
Shweta, S.; Choudhary, P.C.; Intodia, K. Microwave irradiation synthesis of various substituted chalcones using various heterogeneous catalysts under solvent-free conditions and their biological studies. Chem. Sci. Trans., 2013, 2, 343-348.
[http://dx.doi.org/10.7598/cst2013.319]
[33]
Rattan, A.; Churchill, B.I. Antimicrobials in laboratory medicine; Livingstone: New Delhi, 2000, pp. 85-108.
[34]
Robert, C. Medical Microbiology, 11th Ed., ELBS and ES; Living stone: Briton.1970, 895. National committee for clinical laboratory standard, Reference method for broth dilution antifungal susceptibility testing of yeasts approved standard M27A, NCCLS, Wayne PA, 1997.
[35]
Anargyros, P.; Astill, D.S.; Lim, I.S. Comparison of improved BACTEC and Lowenstein-Jensen media for culture of mycobacteria from clinical specimens. J. Clin. Microbiol., 1990, 28(6), 1288-1291.
[http://dx.doi.org/10.1128/JCM.28.6.1288-1291.1990] [PMID: 2116446]
[36]
Shah, R.R.; Mehta, R.D.; Parikh, A.R. Studies on isoniazide derivatives: preparation and antimicrobial activity of 2-aryl-3- (pyridylcarbomyl)-5-carboxymethyl-4-Thiazolidin-4-ones. J. Indian Chem. Soc., 1985, 62B, 255-257.
[37]
The National Committee for Clinical Laboratory Standard. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts Approved Standard M27A; NCCLS: Wayne, PA, 1997.
[38]
Robert, C. Medical Microbiology 11th ed. Briton: ELBS and ES., Livingstone; , 1970, 89, .
[39]
Rieckmann, K.H.; Campbell, G.H.; Sax, L.J.; Mrema, J.E. Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique. Lancet, 1978, 1(8054), 22-23.
[http://dx.doi.org/10.1016/S0140-6736(78)90365-3] [PMID: 74500]
[40]
Desjardins, R.E. Invitro techniques foranti malarial development and evaluation.Handbook of Experimental Pharmacology; Peters, W.; Richards, W.H.G., Eds.; Springer-Verlag: Germany, 1984, pp. 179-200.
[41]
Trager, W.; Jensen, J.B. Human malaria parasites in continuous culture. Science, 1976, 193(4254), 673-675.
[http://dx.doi.org/10.1126/science.781840] [PMID: 781840]
[42]
Lambros, C.; Vanderberg, J.P. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol., 1979, 65(3), 418-420.
[http://dx.doi.org/10.2307/3280287] [PMID: 383936]
[43]
Singh, J.J.S.B.stain A review. Indian J. Malariol., 1956, 10(2), 117-129.
[PMID: 13366404]
[44]
Panjarathinam, R. Text Book of Medical Parasitology, 2nd ed; Orient Longman Pvt. Ltd.: Chennai, 2007, p. 329.

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy